The biomanufacturing sector for advanced therapies is experiencing rapid growth and an escalating demand for personnel with specialized skill sets compared to conventional biopharmaceutical manufacturing. To address this need, OBIO® and CATTI have partnered to deliver the Biomanufacturing for Advanced Therapies Training Program, including cell and gene therapy (CGT), funded by Upskill Canada [powered by Palette Skills] and the Government of Canada.

The program focuses on both conceptual and practical skills essential to the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs), with a curriculum developed through extensive collaborations with companies in the sector developing CGTs and tailored to meet their specialized workforce needs.

The program:

• Cell Culture and Aseptic Techniques Bootcamp: a one-week (~40 hrs), hands-on training course at CATTI’s Guelph facility (on-site) designed for participants to master key skills such as cell culture, aseptic techniques, and good documentation practices, with proficiency assessed by experienced trainers. Other locations may become available in Q2-Q3 of 2025 for the hands-on component of the training. Stay tuned!
• Part-time courses completing the bootcamp: virtual training in advanced therapies Good Manufacturing Practice (GMP), Chemistry, manufacturing, and controls (CMC), Quality Assurance (QA), Intellectual Property (IP) and licensing, and professional skills
• Based on a stackable credentialing approach

To learn more :
https://www.obio.ca/biomanufacturing-for-advanced-therapies